Deka Bank Deutsche Girozentrale Rubius Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.79 - $5.98 $25,201 - $190,762	-31,900 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$4.25 - $10.4 $12,325 - $30,160	2,900 Added 10.0%	31,900 $174,000
Q4 2021 Feb 02, 2022	BUY	$9.68 - $17.74 $7,744 - $14,191	800 Added 2.84%	29,000 $289,000
Q3 2020 Oct 29, 2020	BUY	$4.65 - $6.25 $131,130 - $176,250	28,200 New	28,200 $140,000
Q1 2019 May 10, 2019	SELL	$13.27 - $18.51 $384,830 - $536,790	-29,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$13.83 - $22.97 $401,070 - $666,130	29,000 New	29,000 $457,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.